Townsend Danyelle M, Manevich Yefim, He Lin, Xiong Ying, Bowers Robert R, Hutchens Steven, Tew Kenneth D
Departments of Pharmaceutical and Biomedical Sciences and Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
Cancer Res. 2009 Oct 1;69(19):7626-34. doi: 10.1158/0008-5472.CAN-09-0493. Epub 2009 Sep 22.
The rapid proliferation of cancer cells mandates a high protein turnover. The endoplasmic reticulum (ER) is intimately involved in protein processing. An accumulation of unfolded or misfolded proteins in the ER leads to a cascade of transcriptional and translational events collectively called the unfolded protein response (UPR). Protein disulfide isomerase (PDI) is one of the most abundant ER proteins and maintains a sentinel function in organizing accurate protein folding. Treatment of cells with O(2)-[2,4-dinitro-5-(N-methyl-N-4-carboxyphenylamino)phenyl]1-(N,N-dimethylamino)diazen-1-ium-1,2-diolate (PABA/NO) resulted in a dose-dependent increase in intracellular nitric oxide that caused S-glutathionylation of various proteins. Within 4 h, PABA/NO activated the UPR and led to translational attenuation as measured by the phosphorylation and activation of the ER transmembrane kinase, pancreatic ER kinase, and its downstream effector eukaryotic initiation factor 2 in human leukemia (HL60) and ovarian cancer cells (SKOV3). Cleavage of the transcription factor X-box protein 1 and transcriptional activation of the ER resident proteins BiP, PDI, GRP94, and ERO1 (5- to 10-fold induction) also occurred. Immunoprecipitation of PDI showed that whereas nitrosylation was undetectable, PABA/NO treatment caused S-glutathionylation of PDI. Mass spectroscopy analysis showed that single cysteine residues within each of the catalytic sites of PDI had a mass increase [+305.3 Da] consistent with S-glutathionylation. Circular dichroism confirmed that S-glutathionylation of PDI results in alterations in the alpha-helix content of PDI and is concurrent with inhibition of its isomerase activity. Thus, it appears that S-glutathionylation of PDI is an upstream signaling event in the UPR and may be linked with the cytotoxic potential of PABA/NO.
癌细胞的快速增殖需要高蛋白周转率。内质网(ER)密切参与蛋白质加工。内质网中未折叠或错误折叠蛋白质的积累会引发一系列转录和翻译事件,统称为未折叠蛋白反应(UPR)。蛋白质二硫键异构酶(PDI)是内质网中含量最丰富的蛋白质之一,在组织精确的蛋白质折叠中发挥着哨兵功能。用O(2)-[2,4-二硝基-5-(N-甲基-N-4-羧基苯基氨基)苯基]1-(N,N-二甲基氨基)重氮-1,2-二醇盐(PABA/NO)处理细胞会导致细胞内一氧化氮呈剂量依赖性增加,从而引起各种蛋白质的S-谷胱甘肽化。在4小时内,PABA/NO激活了UPR,并导致翻译衰减,这在人类白血病(HL60)和卵巢癌细胞(SKOV3)中通过内质网跨膜激酶、胰腺内质网激酶及其下游效应物真核起始因子2的磷酸化和激活来衡量。转录因子X-box蛋白1的切割以及内质网驻留蛋白BiP、PDI、GRP94和ERO1的转录激活(诱导5至10倍)也会发生。PDI的免疫沉淀显示,虽然未检测到亚硝化,但PABA/NO处理导致PDI的S-谷胱甘肽化。质谱分析表明,PDI每个催化位点内的单个半胱氨酸残基质量增加[+305.3 Da],与S-谷胱甘肽化一致。圆二色性证实,PDI的S-谷胱甘肽化导致PDI的α-螺旋含量发生变化,并与其异构酶活性的抑制同时发生。因此,PDI的S-谷胱甘肽化似乎是UPR中的上游信号事件,可能与PABA/NO的细胞毒性潜力有关。